These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16358441)

  • 1. Introduction: ethical responsibilities regarding drugs, patents, and health.
    Ryan MP
    Bus Ethics Q; 2005 Oct; 15(4):543-7. PubMed ID: 16358441
    [No Abstract]   [Full Text] [Related]  

  • 2. Some questions about the moral responsibilities of drug companies in developing countries.
    Brock DW
    Dev World Bioeth; 2001 May; 1(1):33-7. PubMed ID: 12870506
    [No Abstract]   [Full Text] [Related]  

  • 3. Social responsibility and global pharmaceutical companies.
    Daniels N
    Dev World Bioeth; 2001 May; 1(1):38-41. PubMed ID: 12870507
    [No Abstract]   [Full Text] [Related]  

  • 4. Intellectual property and pharmaceutical drugs: an ethical analysis.
    De George RT
    Bus Ethics Q; 2005 Oct; 15(4):549-75. PubMed ID: 16358442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to medicines and the rhetoric of responsibility.
    Barry C; Raworth K
    Ethics Int Aff; 2002; 16(2):57-70. PubMed ID: 15709279
    [No Abstract]   [Full Text] [Related]  

  • 6. Developing drugs for the developing world: an economic, legal, moral, and political dilemma.
    Resnik DB
    Dev World Bioeth; 2001 May; 1(1):11-32. PubMed ID: 12870505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The corporate social responsibility of the pharmaceutical industry: idealism without illusion and realism without resignation.
    Leisinger KM
    Bus Ethics Q; 2005 Oct; 15(4):577-94. PubMed ID: 16358443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who's in the business of saving lives?
    Lee Chang P
    J Med Philos; 2006 Oct; 31(5):465-82. PubMed ID: 17079208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction: Pharmaceutical firms and the right to health.
    de Campos TC; Pogge T
    J Law Med Ethics; 2012; 40(2):183-7. PubMed ID: 22789038
    [No Abstract]   [Full Text] [Related]  

  • 10. The Constant Gardener revisited: the effect of social blackmail on the marketing concept, innovation, and entrepreneurship.
    Miles MP; Munilla LS; Covin JG
    J Bus Ethics; 2002 Dec; 41(3):287-95. PubMed ID: 12755097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent immorality?
    Bloche MG; Jungman ER
    Am J Bioeth; 2002; 2(3):48-9. PubMed ID: 12230859
    [No Abstract]   [Full Text] [Related]  

  • 12. Debate on essential medicines heats up.
    Kapp C
    Lancet Infect Dis; 2001 Nov; 1(4):215. PubMed ID: 11871503
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceuticals and medical devices: business practices.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
    [No Abstract]   [Full Text] [Related]  

  • 14. Priceless goods: how should life-saving drugs be priced?
    Maitland I
    Bus Ethics Q; 2002 Oct; 12(4):451-80. PubMed ID: 12708456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
    Berger JM
    Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
    [No Abstract]   [Full Text] [Related]  

  • 16. Intellectual property rights, compulsory licensing and the TRIPS agreement: some ethical issues.
    Schuklenk U
    Monash Bioeth Rev; 2003 Apr; 22(2):63-8. PubMed ID: 15069958
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to commentaries : Resnik, D. B. and K. A. DeVille. 2002. "Bioterrorism and patient rights: 'compulsory licensure' and the case of Cipro." The American Journal of Bioethics 2(3): 29-39.
    Resnik DB; DeVille KA
    Am J Bioeth; 2002; 2(4):W1. PubMed ID: 12816075
    [No Abstract]   [Full Text] [Related]  

  • 18. Transnational pharmaceutical corporations and neo-liberal business ethics in India.
    D'Mello B
    J Bus Ethics; 2002 Mar; 36(1-2):165-85. PubMed ID: 12625343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Not taking, just borrowing: government use of patented drugs.
    Ossorio PN
    Am J Bioeth; 2002; 2(3):51-2. PubMed ID: 12230861
    [No Abstract]   [Full Text] [Related]  

  • 20. Three reasons why a global market in pharmaceutical products is inherently unjust.
    Holm S
    J Soc Philos; 2000; 31(4):391-400. PubMed ID: 15069945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.